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Abstract: Lichtheimia corymbifera is considered as one of the most frequent agents of mucormycosis. 
The lack of efficient genetic manipulation tools hampers the characterization of the 
pathomechanisms and virulence factors of this opportunistic pathogenic fungus. Although such 
techniques have been described for certain species, the performance of targeted mutagenesis and 
the construction of stable transformants have remained a great challenge in Mucorales fungi. In the 
present study, a plasmid-free CRISPR-Cas9 system was applied to carry out a targeted gene 
disruption in L. corymbifera. The described method is based on the non-homologous end-joining 
repair of the double-strand break caused by the Cas9 enzyme. Using this method, short, one-to-five 
nucleotide long-targeted deletions could be induced in the orotidine 5’-phosphate decarboxylase 
gene (pyrG) and, as a result, uracil auxotrophic strains were constructed. These strains are applicable 
as recipient strains in future gene manipulation studies. As we know, this is the first genetic 
modification of this clinically relevant fungus. 
Keywords: mucormycosis; gene disruption; uracil auxotrophy; OMP decarboxylase; non-
homologous end joining; Mucorales 
 
1. Introduction 
Mucormycosis is an invasive opportunistic fungal infection caused by certain members of the 
filamentous fungal order Mucorales [1]. This life-threatening infection can manifest as rhino-orbito-
cerebral, pulmonary, cutaneous, gastrointestinal, or disseminated disease and is notorious for its 
rapid progression and unacceptably high mortality rates (i.e., around 50%, but 90% for disseminated 
cases) [2–4]. It most frequently occurs in patients having an underlying immunocompromised status 
due to immunosuppressive treatment or hematological malignancy but diabetes, especially if 
associated with ketoacidosis, elevated levels of free iron in the blood, critical care and trauma are also 
considered as possible risk factors [1,2,5,6]. The species most frequently identified as the etiological 
agents of mucormycosis belong to the genera Rhizopus, Lichtheimia, and Mucor [5,7,8]. After Rhizopus 
delemar (sometimes also referred to as R. arrhizus var. delemar and R. oryzae) [9], the Lichtheimia species, 
primarily L. corymbifera, are most often recovered from clinical samples, especially in European 
countries [2,4,8]. 
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The frequency of systemic mucormycosis is increasing, mostly because of the broadening of the 
susceptible population [3,8,10]. Successful outcome highly depends on the timely diagnosis and the 
effective antifungal therapy, as well as the reversal of the predisposing factors [1] but, unfortunately, 
diagnosis and treatment of such infections still remain challenging [11]. Furthermore, Mucorales 
fungi display intrinsic resistance to the majority of the routinely used antifungal agents (e.g., candins 
and most azoles), which also limits the possible therapeutic options [1,3]. All these considerations 
urge the improvement of the molecular identification methods and the discovery of new antifungal 
targets and strategies. To achieve these goals, clarification of the pathomechanism of mucormycosis, 
understanding the interaction of these fungi with the hosts, and the identification of potential 
virulence factors and new biomarkers are essential. All these studies need the adaptation and routine 
application of molecular and genetic manipulation methods. 
For Rhizopus and Mucor species, various classical genetic transformation-based molecular 
manipulation methods have been developed and applied [12,13]. Recently, the CRISPR-Cas9 method 
has also been adapted to generate single and multiple gene disruption in Mucor circinelloides [14,15] 
and point mutations in Rhizopus delemar [11]. However, until now, no effective genetic transformation 
methods have been available for L. corymbifera, which seriously hampers the efforts to characterize 
the gene functions and reveal the genetic and molecular background of the pathogenicity of this 
fungus. Therefore, a plasmid-free, in vitro CRISPR-Cas9 method has been adapted and tested to carry 
out targeted gene disruption in L. corymbifera in this study. Using this technique, the pyrG gene 
encoding the orotidine 5’-phosphate decarboxylase (OMP decarboxylase) has been disrupted and a 
uracil auxotrophic strain, which can be used as a recipient strain in further genetic manipulation 
studies, could be created. 
2. Results 
2.1. Disruption of the pyrG Gene in L. corymbifera 
Two guide RNAs (gRNAs) targeting different positions in the L. corymbifera pyrG gene were 
designed and synthesized in vitro (Table 1). L. corymbifera protoplasts were co-transformed directly 
with one of these gRNAs and the Cas9 nuclease. 
Table 1. Sequences of the protospacers designed in the study and positions of the corresponding 




Position in the pyrG Gene 
LcpyrGcr1 acacgactttatgatattcg 315–334 1 
LcpyrGcr2 aatgaacgaacacgacgatg 687–707 
1 Numbers present nucleotide positions downstream from the start codon of the L. corymbifera pyrG 
gene (gene ID: ID: LCOR_02455.1). 
Transformants, in which the targeted pyrG gene had been disrupted, were selected for their 
resistance to 5-fluoroorotic acid (5-FOA). Cells expressing OMP decarboxylase convert 5-FOA to a 
toxic compound, 5-fluorouridine monophosphate and cannot grow if 5-FOA is added to their culture 
medium [16,17]. Thus, colonies, which were unable to express the enzyme because of the mutation 
of the pyrG gene, display 5-FOA resistance and are auxotrophic to uracil (Figure 1). Using 10-10 µM 
gRNA and Cas9, the transformation efficiency was 8 colonies per 105 protoplasts for both gRNAs. 
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Figure 1. An example for the growth of the wild-type and the mutant L. corymbifera strains on yeast 
nitrogen base (YNB) medium (a), YNB medium supplemented with uracil (0.5 g/L) (b) and YNB 
medium supplemented with uracil (0.5 g/L) and 5-FOA (1 g/L) (c). Strains: CBS 429.75, the original 
wild-type strain; CBS 429.75–pyrGCr1/1, one of the mutants, in which the pyrG was disrupted by the 
CRISPR-Cas9 method; CBS 429.75–pyrGcompl/1, the strain, in which the CRISPR-Cas9-generated 
mutation was complemented. Growth was performed at 37 °C for two days. 
2.2. Evidence for CRISPR-Cas9-Mediated Disruption of the pyrG Gene 
The pyrG gene was amplified from the 16 isolated 5-FOA resistant and uracil auxotrophic strains. 
Sequencing of the PCR products indicated one to five nucleotides long deletions at the targeted sites 
(Figure 2) in 10 transformants. These 10 isolates were named as CBS 429.75–pyrGcr1/1–3 and CBS 
429.75–pyrGcr2/1–7, corresponding to the protospacers LcpyrGcr1 and LcpyrGcr2, respectively. No 
mutations were found in the sequences of the fragments amplified from the other six strains. This 
result indicates a genome editing efficiency of 37.5% and 87.5% for the protospacers LcpyrGcr1 and 
LcpyrGcr2, respectively. 
To test their mitotic stability, each disruption mutant was passed several times on selective and 
non-selective media. All strains proved to be mitotically stable, retaining their phenotype (i.e., 5-FOA 
resistance and uracil auxotrophy) and the deletion in the pyrG gene after 5 cultivation cycles under 
non-selective conditions. 
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Figure 2. CRISPR-Cas9 induces deletions in the targeted sites of the L. corymbifera pyrG gene. (a) 
Sequence of the site in the pyrG gene targeted using the LcpyrGcr1 protospacer and location of the 
induced mutations in the three resulting strains. (b) Sequence of the site in the pyrG gene targeted 
using the LcpyrGcr2 protospacer and location of the induced mutations in the seven resulting strains. 
The protospacer and the protospacer adjacent motif (PAM) sequence are highlighted with blue and 
red letters, respectively. (c) Diagram representing the pyrG gene and showing the positions of the 
targeted sites and the primers used to analyze the mutants. 
Transformation of the mutants with the circular plasmid pLcpyrGcompl, which assures the 
expression of the pyrG gene, complemented the uracil auxotrophy and caused sensitivity to 5-FOA 
in the transformants (Figure 1). The plasmid and the PCR analysis of the complemented strains to 
prove the transformation are shown in Figure 3. 
 
Figure 3. (a) Map of the plasmid used to complement the uracil auxotrophy of the CRISPR-Cas9-
generated L. corymbifera mutants. Arrows indicate the recognition sites of the primers used to analyze 
the transformants. (b) An example of the PCR analysis of the complemented mutants. A fragment of 
the transferred plasmid was amplified from the pyrG-complemented CBS 429.75–pyrGcr1/1 strain 
using the primers pJet1.2 forward sequencing primer and LcpyrGrev. Lane M: GeneRuler 1 kb DNA 
Ladder (Thermo Scientific), Lane 1: CBS 429.75–pyrGcompl/1, Lane 2: CBS 429.75–pyrGcompl/2, Lane 3: 
CBS 429.75–pyrGcompl/3. 
2.3. Characterization of the Disruption Mutants 
Apart from their slightly weaker growth, the morphology of the mutants did not differ from that 
of the original strain (Figure 4). 
 
Figure 4. Colony morphology of the original CBS 429.75 and one of the mutants (CBS 429.75–pyrGcr1/1) 
growing on YNB plates at 37 °C. 
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The growth ability of the mutants was tested, cultivating them on minimal medium 
supplemented with uracil at different temperatures for four days and measuring the colony 
diameters daily. Although the pyrG mutants displayed a tendency to grow slightly weaker than the 
parental strain, this difference in their growth did not prove to be significant, except at 37 °C after 
one day of cultivation (Figure 5a). 
Effect of calcofluor white (CFW), sodium dodecyl sulfate (SDS), and Triton X-100 as cell-wall 
and membrane-perturbing compounds on the fungal growth was tested. In general, pyrG disruption 
mutants displayed somewhat weaker growth than the original strain in the presence of these 
compounds (Figure 5b). 
 
Figure 5. Growth of the original L. corymbifera strain (CBS 429.75) and one of the mutants (CBS 429.75–
pyrGcr1/1) at different temperatures (a) and in the presence of different stressors (b). The presented 
values are averages; colony diameters were measured during three independent cultivation (error 
bars indicate standard deviation). Asterisk (*) indicates significant difference from the corresponding 
value of the CBS 429.75 strain according to the paired t-test (p < 0.05). 
Susceptibility of the pyrG disruption mutants and the original strain to oxidative stress was also 
examined. Strains, in which the pyrG gene was disrupted, showed a tendency to slightly higher 
sensitivity to hydrogen peroxide (H2O2) than the parental strain, but this difference was not found to 
be significant (Figure 6a). 
Pathogenicity of the mutants and the original strain did not differ significantly in survival 
experiments using the alternative Drosophila melanogaster model (Figure 6b). 
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Figure 6. (a) Susceptibility of the original L. corymbifera strain (CBS 429.75) and one of the mutants 
(CBS 429.75–pyrGcr1/1) to H2O2. (b) Virulence of the strains CBS 429.75 and CBS 429.75–pyrGcr1/1 in 
Drosophila survival experiments. 
3. Discussion 
L. corymbifera is considered as the second most frequent agent of mucormycosis after R. delemar, 
especially in Europe [2,4,8]. However, efficient genetic transformation or genome edition methods 
have not been available for this fungus, which highly narrows the spectrum of tools applicable in 
genetic and molecular studies of the pathogenicity. At the same time, it is also known that targeted 
gene manipulation is a great challenge in the Mucorales group, and such methods have been 
developed only for certain species, such as M. circinelloides [11–14]. 
Application of the CRISPR-Cas9 system provides a versatile genome editing technique, which 
has already been used to target and disrupt genes in some pathogenic fungi, such as in Aspergillus 
fumigatus [18], Candida albicans [19], C. glabrata [20] or Cryptococcus neoformans [21] Recently, the 
method has also successfully been adapted to two members of Mucorales, M. circinelloides [14,15] and 
R. delemar [11]. 
Various methods have been developed to carry out the CRISPR-Cas9-based genome editing in 
fungi [22]. In vivo expression systems involve the application of plasmids, which assure the 
expression of the Cas9 enzyme and the elements of the gRNA, i.e., the CRISPR-RNA (crRNA) 
containing the protospacer sequence and the trans-activating crRNA (tracrRNA). This strategy was 
used to induce targeted point mutations in the genome of R. delemar and construct a uracil 
auxotrophic strain [11]. It should be mentioned that in vivo systems may have the drawbacks of time-
consuming plasmid construction, the possible presence of heterologous sequences in the genome-
edited strains (such as bacterial antibiotic resistance genes) and maintenance of the plasmid and 
expression of the system after the genome edition event, which may cause off-target effect or other 
interference between the transferred DNA and the host genome [14]. 
In vitro CRISPR-Cas9 systems use a plasmid-free strategy where the purified Cas9 enzyme and 
the in vitro transcribed gRNA complex is transferred together into the recipient cells. Application of 
such in vitro systems can minimalize the chance for the emergence of the off-target effect and assure 
the rapid degradation of the CRISPR-Cas9 ribonucleoprotein complex after the genetic modification 
[23]. This approach was successfully applied to construct single and multiple gene disruption 
mutants in P. chrysogenum [24] and M. circinelloides [14,15]. This in vitro, plasmid-free strategy has 
been adapted to achieve stable, targeted gene disruption in L. corymbifera in the present study. 
Cas9 causes double-strand breaks at the targeted site, which is repaired by either the non-
homologous end joining (NHEJ) or the homology-directed repair (HDR) mechanisms of the cell. The 
latter requires the presence of a template DNA containing sequences homologous with the targeted 
site to drive the homologous recombination. NHEJ generally causes indel (insertion or deletion) 
mutations and can be used for targeted gene disruption. These indel mutations are generally short 
with lengths ranging from one to a few tens of nucleotides in various fungi [11,18,22,25]. In our study, 
NHEJ repair induced various 1–5 nucleotides long deletions in the pyrG gene of L. corymebifera. 
Previously, the same mechanism was used to induce a 1-nucleotide deletion in the pyrF gene of R. 
delemar [11]. Interestingly, NHEJ caused extensive, more than 2 kbp long, deletions in the targeted 
carB and the adjacent genes of M. circinelloides, raising that HDR can be the preferred approach for 
the CRISPR-Cas9 genome editing of that fungus [14]. 
Although 16 5-FOA resistant L. corymbifera strains were isolated, 10 of them harbored deletions 
at the targeted site as a consequence of the CRISPR-Cas9 mutagenesis. 5-FOA resistance can be used 
to select for mutants in the genes pyrF encoding orotate phosphoribosyl transferase and pyrG 
encoding OMP decarboxylase [12,16]. Both genes participate in the uridine biosynthesis pathway and 
their deletion causes uracil auxotrophy. For the two genes, uracil auxotrophic and 5-FOA resistant 
mutants can emerge spontaneously [11,16]. Such spontaneous mutations, possibly in the pyrF gene, 
may have caused the six false-positive colonies. 
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Besides demonstrating the applicability of the CRISPR-Cas9 methods for the genetic 
modification of L. corymbifera, another aim of the study is to construct a stable uracil auxotrophic 
mutant, which can be applied in further gene manipulation and genetic transformation studies as a 
recipient strain. Using this strain, the pyrG gene of L. corymbifera can be applied as a selectable marker. 
Uracil auxotrophy may cause decreased growth and pathogenicity, and several studies have 
demonstrated that the pyrimidine biosynthetic pathway can affect these processes [26–29]. Recently, 
Binder et al. [30] reported that the uracil auxotrophy of M. circinelloides caused decreased virulence 
in the alternative Galleria model. However, uracil or uridine availability and activity of the uptake 
mechanisms can modify these effects in the different species and strains [31]. Therefore, growth 
ability, stress tolerance, and virulence were tested in the mutants. In general, disruption of the pyrG 
gene had a moderate effect on the viability of the mutants. It did not affect the morphology and the 
pathogenicity of the fungus and slightly decreased its growth at certain temperatures and under cell 
wall stress. H2O2 may induce biophysical and permeability changes in the cell membrane [32], 
potentially affecting the uracil uptake in the auxotrophic strains. However, the H2O2 sensitivity of the 
mutants only slightly differed from those of the parental strain. At the same time, complementation 
of the disrupted pyrG gene restored the original phenotype. These results indicate that the pyrG 
mutants can be used as recipient strains in gene manipulation and other functional genetic 
experiments. 
4. Materials and Methods  
4.1. Strains, Media and Growth Conditions 
The L. corymbifera type-strain (CBS 429.75) was used in this study. For nucleic acid extractions, 
106 sporangiospores were plated onto a solid minimal medium (YNB; 10 g glucose, 0.5 g yeast 
nitrogen base without amino acids (BD Difco, Becton Dickinson, Franklin Lakes, NJ, USA), 1.5 g 
(NH4)2SO4, 1.5 g sodium glutamate, and 20 g agar per liter) supplemented with uracil (0.5 mg/mL), if 
required. Fungal cultures were grown for 4 days at 37 °C. To examine the effect of the temperature 
on fungal growth, strains were cultivated on solid YNB supplemented with uracil at 30, 35, 37, and 
40 °C, plating 104 spores onto the medium. To test the mitotic stability of the transformants, malt 
extract agar (MEA; 10 g glucose, 5 g yeast extract, 10 g malt extract, and 20 g agar per liter) was used 
as the complete, non-selective medium. 
4.2. Molecular Techniques and Design of the gRNA 
Genomic DNA was isolated using the ZR Fungal/Bacterial DNA MiniPrep (Zymo Research, 
Irvine, CA, USA) according to the manufacturer’s instructions. PCR products were isolated and 
concentrated using the Zymoclean Large Fragment DNS Recovery Kit (Zymo Research, Irvine, CA, 
USA) and DNA Clean & Concentrator-5 (Zymo Research, Irvine, CA, USA). To design the 
oligonucleotide sequences, sequence data available in the Lichtheimia corymbifera JMRC:FSU:9682 
genome [33] database at the JGI MycoCosm portal 
(https://mycocosm.jgi.doe.gov/Liccor1/Liccor1.home.html) were used. Two different protospacer 
sequences were designed to target the DNA cleavage in the pyrG gene (Lichtheimia corymbifera 
JMRC:FSU:9682 genome database ID: LCOR_02455.1) and named as LcpyrGcr1 and LcpyrGcr2. The 
sequences and positions of the corresponding regions in the genome are presented in Table 1. Using 
these sequences, the crRNA and the tracrRNA molecules were purchased from IDT as Alt-R CRISPR 
crRNA and Alt-R CRISPR-Cas9 tracrRNA, respectively. To form the crRNA:tracrRNA duplex (i.e., 
the gRNA), the Nuclease-Free Duplex Buffer (IDT, Coralville, IA, USA) was used according to the 
instructions of the manufacturer. To prove the mutations generated in the transformants, the pyrG 
gene was amplified by PCR using the Phusion Flash High-Fidelity PCR Master Mix kit (Thermo 
Scientific, Waltham, MA, USA) and the primer pair LcpyrGfw (5′-atgaacaccttcaagacatacag-3′) and 
LcpyrGrev (5′-ctactgcttttgcacacgttc-3′). The amplified fragment was then sequenced commercially by 
LGC Genomics (Berlin, Germany). 
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4.3. Transformation 
The polyethylene glycol (PEG)-mediated protoplast transformation was used to introduce one 
of the gRNAs and the Cas9 enzyme (Alt-R S.p. Cas9 Nuclease; IDT, Coralville, IA, USA) 
simultaneously into the L. corymbifera cells as described earlier for M. circinelloides [14]. Ten µM gRNA 
and 10 µM Cas9 nuclease were added to the protoplasts in one transformation reaction. 
Transformants were selected on solid YNB medium supplemented with 0.8 M sorbitol as an osmotic 
stabilizer, 0.5 g/L uracil, and 1 g/L 5-FOA (Thermo Scientific, Waltham, MA, USA). 
4.4. H2O2 Susceptibility Tests 
The sensitivity of the fungal strains to H2O2 was examined in a 96-well microtiter plate assay. 
H2O2 solution (Sigma Aldrich, St. Louis, MO, USA) was dissolved in liquid YNB medium to prepare 
a 100-mM stock solution. Final concentrations of H2O2 in the wells ranged from 0 to 10 mM; chemicals 
were diluted with liquid YNB medium. Spore suspensions were also prepared in liquid YNB 
(supplemented with 0.5 g/L uracil, if required), and the final amount of the spores in the wells was 
set to 105. Plates were incubated for 48 h at 37 °C and the optical density of the fungal cultures was 
measured at 620 nm using a SPECTROstar Nano (BMG Labtech, Ortenberg, Germany) microplate 
reader. The uninoculated medium was used as the background for the calibration, and fungal growth 
in the H2O2-free medium was considered as 100%; all experiments were performed in triplicates. 
4.5. Effect of Cell Wall Stressors 
Fungal spores (104/mL) were point-inoculated at the center of solid YNB media (supplemented 
with 0.5 g/L uracil, if required) containing 1 µL/mL Triton-X 100 (Sigma Aldrich, St. Louis, MO, USA), 
0.04 mg/mL SDS (Sigma Aldrich, St. Louis, MO, USA) or 0.1 mg/mL CFW (Sigma Aldrich, St. Louis, 
MO, USA) as the tested stressors. The diameter of the colonies was measured daily after incubating 
the plates at 37 °C. 
4.6. Survival Experiments in Drosophila Melanogaster 
Pathogenicity of the original CBS 429.75 L. corymbifera strain and one of the constructed mutants 
(CBS 429.75-pyrGcr1/1) was tested in D. melanogaster. Spore suspensions were prepared with sterile 
phosphate buffer saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) 
from 4-day-old cultures grown on YNB plates (supplemented with 0.5 g/L uracil, if required) at 37 
°C. The final inoculum concentrations were adjusted to 1 × 107 spores/mL with PBS. Drosophila stocks 
were raised and kept following the infection on standard cornmeal agar medium at 25 °C. The Oregon 
R strain, originally obtained from the Bloomington stock center, was used as the wild-type 
throughout the experiments. Infection was performed by dipping a thin needle in a suspension of 
fungal conidia (107 conidia/mL) or PBS for the uninfected control, and, subsequently, the thorax of 
the anesthetized fly was pricked. Flies were counted at different points of time to monitor survival. 
Flies were moved into fresh vials every other day. Each experiment was performed with 
approximately 60 flies for each genotype. The results shown are representative of at least three 
independent experiments. 
4.7. Construction of Plasmids for the Complementation of Uracil Auxotrophy 
The pyrG gene with its own promoter and terminator sequences was amplified by PCR using 
the Phusion Flash High-Fidelity PCR Master Mix (Thermo Scientific, Waltham, MA, USA) and the 
primer pair LcpyrG1 (5′-gtaatagcaaggaccaccgagtga-3′) and LcpyrG2 (5′-gaacaattaagagccgttgaatcc-3′). 
The amplified fragment was ligated into the pJet1.2 cloning vector (Thermo Scientific, Waltham, MA, 
USA), arising the plasmid pLcpyrGcompl (Figure 3a), which was used to complement the uracil 
auxotrophy of the pyrG disrupted mutants. The plasmid was transformed into the mutants by PEG-
mediated protoplast transformation. Transformants were selected on YNB plates without the 
addition of uracil. One transformant colony was isolated and analyzed for each mutant. The presence 
of the plasmids and the pyrG gene in the transformants were proven by PCR using the pJet1.2 forward 
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sequencing primer (5′-cgactcactatagggagagcggc-3′), which has the binding site on the plasmid, and 
the LcpyrGrev primer (Figure 3b). 
4.8. Statistical Analyses 
All measurements were performed in at least two technical and three biological replicates. 
Significance was calculated with paired t-test using Microsoft Excel of the Microsoft Office package 
(Microsoft, Redmond, WA, USA). P-values less than 0.05 were considered statistically significant. 
5. Conclusions 
A plasmid-free, in vitro CRISPR-Cas9 system was adopted to carry out targeted mutagenesis in 
L. corymbifera. Our results demonstrate that the CRISPR-Cas9 method based on NHEJ is applicable to 
induce short, targeted deletions in the genes of this fungus. Using the described technique, the pyrG 
gene encoding the OMP decarboxylase has been disrupted. The resulting uracil auxotrophic L. 
corymbifera strains can be applied as recipient strains in further genetic manipulation studies. As we 
know, this is the first targeted gene manipulation of this mucormycosis-causing fungus. 
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Abbreviations 
5-FOA 5-fluoroorotic acid 
Cas9 CRISPR-associated protein 9 
CFW calcofluor white 
CRISPR clustered regularly interspaced short palindromic repeats 
crRNA CRISPR-RNA 
gRNA guide RNA 
H2O2 hydrogen peroxide 
HDR Homology-directed repair 
MEA malt extract agar 
NHEJ non-homologous end-joining 
OMP orotidine 5’-phosphate 
PAM protospacer adjacent motif 
PBS phosphate buffer saline 
PEG polyethylene glycol 
pyrF orotate phosphoribosyl transferase gene 
pyrG orotidine 5’-phosphate decarboxylase gene 
SDS sodium dodecyl sulfate 
tracrRNA trans-activating crRNA 
YNB yeast nitrogen base 
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